The medtech IPO window is finally open. Or is it?

After a three-year IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of activity.

By Ricky Zipp • May 29, 2025

Boston Scientific ends TAVR sales; J&J shares Monarch robot data

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory requirements.”

By Elise Reuter • May 28, 2025

FDA finds Chinese lab copied or falsified data, endangering patients

The FDA said the findings raise doubts about the reliability and viability of premarket submissions based on the company’s data.

By Nick Paul Taylor • May 28, 2025

Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition

Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired with MitraClip.

By Susan Kelly • May 28, 2025

Zimmer hires former Nevro CEO Kevin Thornal

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.

By Susan Kelly • May 27, 2025

Trump calls for 50% tariffs on EU

The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.

By Philip Neuffer • Updated May 27, 2025

BD recalls esophagogastric tubes linked to 2 serious injuries, 1 death

A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.

By Nick Paul Taylor • May 27, 2025

Stryker wins FDA clearance for minimally invasive back pain treatment

The company will compete with a device Boston Scientific acquired for $850 million.

By Nick Paul Taylor • May 22, 2025

Why Medtronic plans to spin out its diabetes business

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on segments with higher margins.

By Elise Reuter • May 22, 2025

Cost cuts, production shifts: How medtech firms are managing tariffs

Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade standoff.

By Susan Kelly • May 22, 2025

Merit buys hemostatic device maker Biolife for $120M

Merit CEO Fred Lampropoulos said Biolife’s StatSeal and WoundSeal devices “address an estimated $350 million global market opportunity.”

By Nick Paul Taylor • May 21, 2025

AI in medtech is booming. Track new devices here.

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.

By Elise Reuter , Jasmine Ye Han • May 20, 2025

J&J subsidiary ordered to pay $147M for violating antitrust rules

A jury found that Biosense Webster withheld services to hospitals using reprocessed catheters.

By Elise Reuter • May 20, 2025

EndoQuest, Virtuoso begin clinical trials for surgical robots

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed bladder lesion excision in six patients.

By Susan Kelly • May 19, 2025

US signals reciprocal tariffs will return for some countries

The White House will alert countries of their specific rates in the next two to three weeks, President Donald Trump said Friday.

By Philip Neuffer • Updated May 20, 2025

Beyond sterility: The quiet engineering challenge behind every safe medical device

Inside the evolving science of sterilization compatibility and why your next packaging decision might improve patient outcomes.

May 19, 2025

House committees advance reconciliation text with big impacts on healthcare

Republicans in Energy and Commerce and Ways and Means have approved their portions of President Donald Trump’s “big, beautiful bill” after marathon markups. Here’s an extensive look at what the legislation means for healthcare.

By Rebecca Pifer • May 16, 2025

Siemens Healthineers invests $150M in US, moves production from Mexico

News of the investment comes one week after Siemens Healthineers said tariffs will have a pretax impact of up to 300 million euros.

By Nick Paul Taylor • May 16, 2025

Intuitive CEO Gary Guthart to step down after 15 years

Dave Rosa, Intuitive Surgical’s president, will take over as chief executive on July 1, as the surgical robot maker accelerates the rollout of its latest da Vinci system.

By Susan Kelly • May 15, 2025

AdvaMed CEO Scott Whitaker pleads for tariff relief in Senate hearing

Whitaker repeated a call for “zero-for-zero” reciprocal tariffs between the U.S. and its trade partners in testimony before a Senate Finance Committee panel on critical supply chains.

By Susan Kelly • May 14, 2025

European Commission readies countermeasures to US tariffs

The commission is taking steps to target roughly $107 billion worth of imports if it can’t make a tariff deal with the U.S.

By Antone Gonsalves • May 14, 2025

Philips taps Nvidia to build AI model for MRI

Philips wants to create a foundation model for MRI to address challenges that are specific to the imaging technique.

By Nick Paul Taylor • May 14, 2025

Embecta restructures again, outlines tariff costs

The diabetes tech company announced a second restructuring after ending its insulin patch-pump program.

By Elise Reuter • May 13, 2025

Vicarious Surgical, UMass partner; SS Innovations targets de novo submission

Vicarious Surgical and SS Innovations marked progress toward bringing their robotic surgery systems to the U.S. market. The companies are among a new generation of robot developers planning to challenge Intuitive Surgical.

By Susan Kelly • May 13, 2025

Teal wins FDA approval for at-home cervical cancer screening device

The company plans to start shipping the device in June, starting in California and then expanding nationwide.

By Nick Paul Taylor • May 13, 2025